Pfizer (PFE)

Total Liabilities

$115.64B

Quarterly · Period ending: · USD

PFE logo

PFE Total Liabilities

Latest reported$115.64B
PFE Quarterly Total Liabilities ($1.54B → $115.64B)
High-resolution chart · PNG

PFE total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
115,639,000,000
117,214,000,000
121,385,000,000
115,635,000,000
117,083,000,000
117,391,000,000
124,899,000,000
126,918,000,000
128,218,000,000
128,537,000,000
137,213,000,000
117,817,000,000
120,875,000,000
94,381,000,000
101,289,000,000
102,459,000,000
107,821,000,000
101,156,000,000
104,014,000,000
103,221,000,000
99,605,000,000
89,953,000,000
90,756,000,000
113,488,000,000
113,370,000,000
100,998,000,000
104,147,000,000
105,050,000,000
96,275,000,000
96,263,000,000
95,664,000,000
96,174,000,000
94,856,000,000
94,071,000,000
100,141,000,000
111,041,000,000
109,864,000,000
110,038,000,000
111,775,000,000
114,829,000,000
107,592,000,000
99,582,000,000
102,383,000,000
103,743,000,000
93,698,000,000
93,053,000,000
95,944,000,000
93,057,000,000
95,656,000,000
93,740,000,000
95,481,000,000
97,167,000,000
100,358,000,000
104,571,000,000
104,120,000,000
100,488,000,000
102,881,000,000
102,006,000,000
105,381,000,000
105,602,000,000
106,936,000,000
104,423,000,000
106,749,000,000
103,347,000,000
104,193,000,000
105,031,000,000
122,503,000,000
75,044,000,000
76,104,000,000
62,491,000,000
53,408,000,000
47,758,000,000
49,797,000,000
50,990,000,000
50,144,000,000
42,420,000,000
42,309,000,000
37,995,000,000
44,114,000,000
38,873,000,000
43,061,000,000
43,350,000,000
51,206,000,000
43,536,000,000
46,999,000,000
55,403,000,000
54,800,000,000
53,846,000,000
53,256,000,000
53,241,000,000
51,398,000,000
51,527,000,000
53,976,000,000
28,085,000,000
26,406,000,000
25,923,000,000
23,738,000,000
21,642,000,000
20,860,000,000
19,910,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.